{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:26:59Z","timestamp":1787668019162,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cdn.nutrition.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Developments in Nutrition"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.cdnut.2024.102083","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T12:10:05Z","timestamp":1705666205000},"page":"102083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Rong-Hong","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ju","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Kai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hsiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Fu","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-1748","authenticated-orcid":false,"given":"Ming-Ta","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.cdnut.2024.102083_bib1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cdnut.2024.102083_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/145754","article-title":"Diagnosis and evaluation of nonalcoholic fatty liver disease","volume":"2012","author":"Obika","year":"2012","journal-title":"Exp. Diabetes Res."},{"issue":"1","key":"10.1016\/j.cdnut.2024.102083_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"issue":"6","key":"10.1016\/j.cdnut.2024.102083_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jceh.2019.06.003","article-title":"Antidiabetic drugs and statins in nonalcoholic fatty liver disease","volume":"9","author":"Kothari","year":"2019","journal-title":"J.\u00a0Clin. Exp. Hepatol."},{"issue":"2","key":"10.1016\/j.cdnut.2024.102083_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/tcmj.tcmj_86_20","article-title":"Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes","volume":"33","author":"Prabhakar","year":"2021","journal-title":"Tzu. Chi. Med. J."},{"issue":"28","key":"10.1016\/j.cdnut.2024.102083_bib6","first-page":"9338","article-title":"Role of diet and lifestyle changes in nonalcoholic fatty liver disease","volume":"20","author":"Nseir","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cdnut.2024.102083_bib7","first-page":"18","article-title":"Dietary recommendations for patients with nonalcoholic fatty liver disease","volume":"9","author":"Kargulewicz","year":"2014","journal-title":"Prz. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cdnut.2024.102083_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.amjmed.2014.10.014","article-title":"The Mediterranean diet, its components, and cardiovascular disease","volume":"128","author":"Widmer","year":"2015","journal-title":"Am. J. Med."},{"issue":"19","key":"10.1016\/j.cdnut.2024.102083_bib9","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","article-title":"Mediterranean diet and nonalcoholic fatty liver disease","volume":"24","author":"Anania","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cdnut.2024.102083_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12938\/bmfh.18-032","article-title":"The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms","volume":"38","author":"Jasirwan","year":"2019","journal-title":"Biosci. Microbiota Food Health"},{"key":"10.1016\/j.cdnut.2024.102083_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.906511","article-title":"Effects of dietary nutrients on fatty liver disease associated with metabolic dysfunction (MAFLD): based on the intestinal-hepatic axis","volume":"9","author":"Yao","year":"2022","journal-title":"Front. Nutr."},{"issue":"12","key":"10.1016\/j.cdnut.2024.102083_bib12","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.3390\/ijms22126485","article-title":"Nonalcoholic fatty liver disease (NAFLD) as model of gut-liver axis interaction: from pathophysiology to potential target of treatment for personalized therapy","volume":"22","author":"Fianchi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cdnut.2024.102083_bib13","article-title":"Probiotics for the improvement of metabolic profiles in patients with metabolic-associated fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cdnut.2024.102083_bib14","article-title":"Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases","volume":"64","author":"Cao","year":"2020","journal-title":"J.\u00a0Funct. Foods"},{"issue":"3","key":"10.1016\/j.cdnut.2024.102083_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jobcr.2023.03.013","article-title":"Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives","volume":"13","author":"A","year":"2023","journal-title":"J.\u00a0Oral Biol. Craniofac. Res."},{"key":"10.1016\/j.cdnut.2024.102083_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clnesp.2020.06.020","article-title":"The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled, clinical trial","volume":"39","author":"Abhari","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"issue":"11","key":"10.1016\/j.cdnut.2024.102083_bib17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.cdnut.2024.102083_bib18","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3390\/diagnostics11122341","article-title":"The prevalence of liver steatosis and fibrosis assessed by vibration-controlled transient elastography and controlled attenuation parameter in apparently healthy Romanian medical students","volume":"11","author":"Nastasa","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cdnut.2024.102083_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clnesp.2023.10.001","article-title":"Investigation about the correlation between the severity of metabolic-associated fatty liver disease and adherence to the Mediterranean diet","volume":"58","author":"Mokhtare","year":"2023","journal-title":"Clin. Nutr. ESPEN."},{"issue":"1","key":"10.1016\/j.cdnut.2024.102083_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","article-title":"The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroScan","volume":"36","author":"Sasso","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cdnut.2024.102083_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12929-022-00869-0","article-title":"Enrichment of prevotella intermedia in human colorectal cancer and its additive effects with fusobacterium nucleatum on the malignant transformation of colorectal adenomas","volume":"29","author":"Lo","year":"2022","journal-title":"J.\u00a0Biomed. Sci."},{"issue":"1","key":"10.1016\/j.cdnut.2024.102083_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jceh.2018.02.010","article-title":"Controlled attenuation parameter for assessment of hepatic steatosis in Indian patients","volume":"9","author":"Rout","year":"2019","journal-title":"J.\u00a0Clin. Exp. Hepatol."},{"issue":"3","key":"10.1016\/j.cdnut.2024.102083_bib23","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations","volume":"51","author":"Cast\u00e9ra","year":"2020","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cdnut.2024.102083_bib24","article-title":"Comprehensive genome analyses of Sellimonas intestinalis, a potential biomarker of homeostasis gut recovery","volume":"6","author":"Mu\u00f1oz","year":"2020","journal-title":"Microb. Genom."},{"issue":"2","key":"10.1016\/j.cdnut.2024.102083_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/157016307781483469","article-title":"Current treatment strategies for non-alcoholic fatty liver disease (NAFLD)","volume":"4","author":"Mishra","year":"2007","journal-title":"Curr. Drug Discov. Technol."},{"issue":"44","key":"10.1016\/j.cdnut.2024.102083_bib26","doi-asserted-by":"crossref","first-page":"16452","DOI":"10.3748\/wjg.v20.i44.16452","article-title":"Obesity, fatty liver disease and intestinal microbiota","volume":"20","author":"Arslan","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cdnut.2024.102083_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3164\/jcbn.13-49","article-title":"Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats","volume":"54","author":"Fukunishi","year":"2014","journal-title":"J.\u00a0Clin. Biochem. Nutr."},{"issue":"1","key":"10.1016\/j.cdnut.2024.102083_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ceh.2019.83151","article-title":"Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease","volume":"5","author":"Augustyn","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"issue":"5","key":"10.1016\/j.cdnut.2024.102083_bib29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/microorganisms9050957","article-title":"Gut microbiota and NAFLD: pathogenetic mechanisms, microbiota signatures, and therapeutic interventions","volume":"9","author":"Hrncir","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.cdnut.2024.102083_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1004911","article-title":"Gut microbiota therapy for nonalcoholic fatty liver disease: evidence from randomized clinical trials","volume":"13","author":"Han","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cdnut.2024.102083_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tifs.2023.06.013","article-title":"Targeting gut microbiota and metabolism as the major probiotic mechanism \u2013 an evidence-based review","volume":"138","author":"Ma","year":"2023","journal-title":"Trends Food Sci. Technol."},{"issue":"3","key":"10.1016\/j.cdnut.2024.102083_bib32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J.\u00a0Hepatol."},{"issue":"3","key":"10.1016\/j.cdnut.2024.102083_bib33","first-page":"129","article-title":"Probiotics and nonalcoholic fatty liver disease","volume":"5","author":"Eslamparast","year":"2013","journal-title":"Middle East J. Dig. Dis."},{"issue":"4","key":"10.1016\/j.cdnut.2024.102083_bib34","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/ijfs.13044","article-title":"Evaluation of the stability of Bacillus coagulans MTCC 5856 during processing and storage of functional foods","volume":"51","author":"Majeed","year":"2016","journal-title":"Int. J. Food Sci. Technol."},{"issue":"2","key":"10.1016\/j.cdnut.2024.102083_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cdnut.2024.102083_bib36","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3390\/nu11112642","article-title":"The role of probiotics in nonalcoholic fatty liver disease: a new insight into therapeutic strategies","volume":"11","author":"Meroni","year":"2019","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.cdnut.2024.102083_bib37","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3390\/nu14091965","article-title":"Bifidobacterium animalis ssp. Lactis MG741 reduces body weight and ameliorates nonalcoholic fatty liver disease via improving the gut permeability and amelioration of inflammatory cytokines","volume":"14","author":"Do","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.cdnut.2024.102083_bib38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","article-title":"Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases","volume":"39","author":"Loguercio","year":"2005","journal-title":"J.\u00a0Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cdnut.2024.102083_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-011-1887-4","article-title":"Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis","volume":"57","author":"Malaguarnera","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cdnut.2024.102083_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5487659","article-title":"Protective role of probiotic supplements in hepatic steatosis: a rat model study","volume":"2020","author":"Azarang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cdnut.2024.102083_bib41","article-title":"Bacillus coagulans TL3 inhibits LPS-induced caecum damage in rat by regulating the TLR4\/MyD88\/NF-kappaB and Nrf2 signal pathways and modulating intestinal microflora","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"issue":"12","key":"10.1016\/j.cdnut.2024.102083_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210120","article-title":"Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice","volume":"13","author":"Kim","year":"2018","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.cdnut.2024.102083_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/biomedicines10010084","article-title":"Bifidobacterium bifidum shows more diversified ways of relieving non-alcoholic fatty liver compared with Bifidobacterium adolescentis","volume":"10","author":"Wang","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cdnut.2024.102083_bib44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fmicb.2016.00713","article-title":"The common gut microbe eubacterium hallii also contributes to intestinal propionate formation","volume":"7","author":"Engels","year":"2016","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.cdnut.2024.102083_bib45","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3390\/biomedicines10081797","article-title":"Effects\u00a0of resveratrol administration in liver injury prevention as\u00a0induced by an obesogenic diet: role of Ruminococcaceae","volume":"10","author":"Milton-Laskibar","year":"2022","journal-title":"Biomedicines"},{"issue":"21","key":"10.1016\/j.cdnut.2024.102083_bib46","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.3390\/nu14214475","article-title":"Co-cultures of lactobacillus acidophilus and Bacillus subtilis enhance mucosal barrier by modulating gut microbiota-derived short-chain fatty acids","volume":"14","author":"Xie","year":"2022","journal-title":"Nutrients"}],"container-title":["Current Developments in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247529912400009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247529912400009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:46:01Z","timestamp":1762865161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247529912400009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S247529912400009X"],"URL":"https:\/\/doi.org\/10.1016\/j.cdnut.2024.102083","relation":{},"ISSN":["2475-2991"],"issn-type":[{"value":"2475-2991","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Current Developments in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cdnut.2024.102083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}],"article-number":"102083"}}